2 stunning small-cap dividend stocks I’d buy today

These small-cap stocks could be due for a re-rating, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The magic of investing in successful small-cap stocks is that they can often grow into much larger companies than you might expect. And if they operate in a field dominated by larger firms, there’s always the possibility of a takeover bid.

I believe both of these potential attractions apply to the two companies I’m looking at today.

A smart acquisition

Packaging firm Macfarlane Group (LSE: MACF) has announced plans for a step change in the size of its operations. The company will pay up to £16.75m to acquire Nottingham-based peer Greenwoods Stock Boxes Limited.

The deal will be funded with a mix of cash and new shares, and as part of this process Macfarlane will raise £8m in a share placing to help fund the deal. Although this creates some dilution for shareholders, the firm still expects Greenwoods to make a positive contribution to earnings in the first full year of ownership.

This acquisition certainly seems attractive to me. Greenwoods generated an operating profit of £1.6m last year from sales of £14.1m. That gives the firm an operating margin of 11%, more than twice the 4.9% margin generated Macfarlane’s 2016 operating profit of £7.8m. So this deal should help to lift the combined company’s profit margin, boosting future returns.

If Greenwoods fails to perform as expected, Macfarlane will be able to claw back £3.25m in cash, as this will only be paid if certain trading targets are met over the next year.

Cross-selling opportunities

Management says that there is “minimal overlap” between the two companies. They expect the combined group’s shared customer base to provide new selling opportunities, which sounds positive to me.

Macfarlane stock currently trades on a forecast P/E of 11, with a prospective dividend yield of 3.2%. If Greenwoods performs as expected, I believe there’s scope for decent gains over the next couple of years. I’d rate this stock as a buy after today’s news.

Due for re-rating?

I have to admit that the performance of electric shower and bathroom fittings group Norcros (LSE: NXR) has been a little disappointing in recent years. This firm owns brands such as Triton Showers, Vado, Jonson Tiles and Croydex and operates in the UK and South Africa.

Despite generating stable profits, reliable dividends and strong cash generation, the company’s shares trade on a forecast P/E of just 6.1. One reason for the market’s caution may be the group’s pension deficit. At £62.7m, this is quite large when compared to the market cap of £104m.

However, this deficit is largely the result of ultra-low bond yields. If the Bank of England raises interest rates as expected in November, bond yields could strengthen. In common with many companies, Norcros would only need a relatively small increase in bond yields for its deficit to fall significantly.

In my opinion, this is fundamentally a good company, with a robust business and good long-term growth potential. I think it makes sense to keep the faith for a little longer yet.

Based on last year’s figures, I expect this year’s forecast dividend yield of 4.5% to be well covered by free cash flow. And as I’ve already mentioned, a low forecast P/E of 6.1 means that Norcros stock has scope for re-rating if it can deliver on growth forecasts.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Norcros. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »